PRICE T ROWE ASSOCIATES INC /MD/ - CATABASIS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$151,000
-28.8%
71,800
-2.0%
0.00%
Q1 2021$212,00073,2290.00%
Other shareholders
CATABASIS PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 4,092,166$8,634,0003.55%
COMMODORE CAPITAL LP 1,617,000$3,412,0001.19%
ACUTA CAPITAL PARTNERS, LLC 1,173,674$2,476,0000.99%
VR Adviser, LLC 3,234,000$6,824,0000.83%
Logos Global Management LP 3,190,000$6,731,0000.57%
Cormorant Asset Management, LP 3,550,000$7,490,0000.25%
Soleus Capital Management, L.P. 775,000$1,635,0000.25%
Perceptive Advisors 15,374,370$32,438,0000.21%
RA Capital Management 5,947,861$12,550,0000.20%
SILVERARC CAPITAL MANAGEMENT, LLC 188,777$398,0000.18%
View complete list of CATABASIS PHARMACEUTICALS IN shareholders